CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 123 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $25,000 | -51.9% | 1,500 | -25.0% | 0.01% | -55.2% |
| Q4 2017 | $52,000 | +246.7% | 2,000 | +100.0% | 0.03% | +222.2% |
| Q3 2017 | $15,000 | +7.1% | 1,000 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $14,000 | -46.2% | 1,000 | -33.3% | 0.01% | -43.8% |
| Q1 2017 | $26,000 | +23.8% | 1,500 | -25.0% | 0.02% | +23.1% |
| Q4 2016 | $21,000 | +5.0% | 2,000 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $20,000 | +17.6% | 2,000 | +33.3% | 0.01% | +8.3% |
| Q2 2016 | $17,000 | – | 1,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,200,000 | $37,532,000 | 7.45% |
| BVF INC/IL | 2,336,609 | $39,863,000 | 6.78% |
| ISZO CAPITAL MANAGEMENT LP | 152,988 | $2,610,000 | 4.54% |
| SENZAR ASSET MANAGEMENT, LLC | 416,845 | $7,111,000 | 1.80% |
| INGALLS & SNYDER LLC | 1,056,000 | $18,015,000 | 0.96% |
| Lyon Street Capital, LLC | 86,011 | $1,467,000 | 0.59% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 430,982 | $7,353,000 | 0.25% |
| AWM Investment Company, Inc. | 137,212 | $2,340,000 | 0.22% |
| ACUTA CAPITAL PARTNERS, LLC | 49,051 | $837,000 | 0.20% |
| Schonfeld Strategic Advisors LLC | 61,831 | $1,055,000 | 0.11% |